As shown in Fig. 6H, J, HDGF was increased by gefitinib administration in PC-9 xenograft tumors with HDGF overexpression (P < 0.05), and other changes in HDGF and p-EGFR in tumor tissues were consistent with the cell experiments. This evidence concerns the gene EGFR and neoplasm.